-
INZY Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Inozyme Pharma (INZY)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.39 mm | 21.39 mm | 21.39 mm | 21.39 mm | 21.39 mm | 21.39 mm |
Cash burn (monthly) | 1.16 mm | 1.13 mm | 9.06 mm | 8.67 mm | 6.40 mm | 7.66 mm |
Cash used (since last report) | 2.78 mm | 2.68 mm | 21.58 mm | 20.66 mm | 15.24 mm | 18.25 mm |
Cash remaining | 18.62 mm | 18.71 mm | -190.88 k | 732.93 k | 6.15 mm | 3.14 mm |
Runway (months of cash) | 16.0 | 16.6 | -0.0 | 0.1 | 1.0 | 0.4 |
13F holders | Current |
---|---|
Total holders | 109 |
Opened positions | 35 |
Closed positions | 18 |
Increased positions | 34 |
Reduced positions | 17 |
13F shares | Current |
---|---|
Total value | 144.74 bn |
Total shares | 65.53 mm |
Total puts | 5.10 k |
Total calls | 2.60 k |
Total put/call ratio | 2.0 |
Largest owners | Shares | Value |
---|---|---|
Adage Capital Partners GP, L.L.C. | 5.16 mm | $14.29 bn |
Pivotal bioVenture Partners Fund I | 4.49 mm | $26.57 mm |
Pivotal bioVenture Partners Investment Advisor | 4.49 mm | $12.45 bn |
Sofinnova Investments | 4.28 mm | $11.86 bn |
Longitude Capital Partners III | 4.17 mm | $20.96 mm |
Affinity Asset Advisors | 3.97 mm | $11.00 bn |
Rock Springs Capital Management | 3.86 mm | $10.70 bn |
BlackRock | 3.81 mm | $10.56 bn |
Vanguard | 2.63 mm | $7.29 bn |
NEA Management | 2.44 mm | $6.75 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Oct 24 | Erik Harris | Stock Option Common Stock | Grant | Acquire A | No | No | 5.06 | 56,000 | 283.36 k | 56,000 |
30 Sep 24 | Matthew Winton | Common Stock | Grant | Acquire A | No | No | 4.45 | 1,710 | 7.61 k | 4,898 |
30 Sep 24 | Treco Douglas A | Common Stock | Grant | Acquire A | No | No | 4.45 | 1,710 | 7.61 k | 22,375 |
18 Jun 24 | Edwards Martin | Stock Option Common Stock | Grant | Acquire A | No | No | 4.4 | 28,000 | 123.20 k | 28,000 |